Stimulus-responsive self-assembled prodrugs in cancer therapy

Small-molecule prodrugs have become the main toolbox to improve the unfavorable physicochemical properties of potential therapeutic compounds in contemporary anti-cancer drug development. Many approved small-molecule prodrugs, however, still face key challenges in their pharmacokinetic (PK) and phar...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Xiao, Brahma, Rajeev K., Fang, Chao, Yao, Shao Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006903/
https://www.ncbi.nlm.nih.gov/pubmed/35509461
http://dx.doi.org/10.1039/d2sc01003h

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006903/
https://www.ncbi.nlm.nih.gov/pubmed/35509461
http://dx.doi.org/10.1039/d2sc01003h

Ejemplares similares